Spectrum Therapeutics Announces Partnership with Medical Pharmacies

- August 8th, 2019

Spectrum Therapeutics, the medical division of Canopy Growth (NYSE:CGC,TSX:WEED), announced a five year service agreement with Medical Pharmacies Group. As quoted in the press release: Under the agreement, Spectrum Therapeutics will be the preferred medical cannabis education partner to Medical Pharmacies and the seniors it serves in over 500 residences and care facilities. “Many seniors … Continued

Spectrum Therapeutics, the medical division of Canopy Growth (NYSE:CGC,TSX:WEED), announced a five year service agreement with Medical Pharmacies Group.

As quoted in the press release:

Under the agreement, Spectrum Therapeutics will be the preferred medical cannabis education partner to Medical Pharmacies and the seniors it serves in over 500 residences and care facilities.

“Many seniors still face significant barriers when it comes to access and knowledge around the therapeutic value of medical cannabis,” said Dr. Mark Ware, Chief Medical Officer, Canopy Growth. “However with the knowledge and support of trained pharmacists along with Apollo Cannabis Clinics and our full-spectrum range of medical cannabis which includes Softgels, a consistent dosing format of ingestible medical cannabis, we’re ensuring the highest degree of safety and efficacy of medical cannabis is available to this patient population.”

Click here to read the full press release.

Find out what experts are saying about the future of cannabis

 
Read our new report today
 

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

Leave a Reply

Your email address will not be published. Required fields are marked *